Medical Materiel Quality Control (MMQC) & Army-Medical Materiel Instructions (MMI)
USAMMA's Distribution Operations Center (USAMMA DOC) primary focus with the DoD MMQC messages is to support the service specific logisticians, supply managers, and/or pharmacists in assuring the proper suspension of use, handling, and return of recalled materiel is accomplished. USAMMA DOC is responsible for disseminating MMQC on behalf of the Defense Logistics Agency in support of the combat combatant leaders, deployed service members and MHS registered customers.
MHS DMLSS USER: DHA MEDLOG has established the ECRI Hazard Alerts and Recalls (HAR) Notifications.
Customers with questions with regards to the HAR Notification process please contact the DHA-MEDLOG, Chief, Quality and Optimization Branch at 301-619-9851, DSN: 343-9851
Note: This is an informational page for the DOC MMQC/MMI Program. To access the MMQC/MMI Message search, subscription and POC information visit MMQC / MMI Message Response and Subscriber Management
USAMMA DOC creates, publishes, and distributes DoD-MMQC messages and Army-Medical Materiel Instructions (MMI) messages to subscribed customers for all medical materiel. These messages contain urgent information of system-wide interest, including:
Suspension of medical materiel
Extension of storage time periods (potency expiration dates) Disposition instructions Other significant quality control information
The MMQC program monitors and directs appropriate DoD action with respect to voluntary and involuntary medical product recalls, hazard alerts, and advisory notices to assure that the proper use, handling, and return of recalled product is accomplished to protect patient safety. Quality control data comes from pharmaceutical and/or medical device and equipment manufacturers regarding their products.
FDA recalls are classified as follows:
Class I: A situation in which there is a reasonable probability that the use of, or exposure to, a dangerous product will cause serious adverse health consequences or death.
Class II: A situation in which the use of, or exposure to, a dangerous product may cause adverse health consequences.
Class III: A situation in which the use of, or exposure to, a dangerous product is not likely to cause adverse health consequences.
Medical Logistics Policies
Customer can request access and become a member of ECRI Institute to receive the Hazard Alerts and Recalls (HAR) notification. In order to do so, please complete the following form: ECRI User Registration Form
Once completed, please submit to your perspective agency for approval listed below:
READ ONLY ACCESS: Customers requesting read only access can submit their forms directly via email to: email@example.com.
POC FOR SUBMISSION OF ECRI REQUEST (OTHER THAN READ ONLY):
ECRI INSTITUTE TRAINING GUIDES